New obesity clinical guidelines, that doctors in the UK must follow as part of their national contracts with the National Health Services, have just been issued by NICE (the National Institute for Health and Clinical Excellence). They recommend rimonabant (Acomplia) for all ‘overweight’ and ‘obese’ people who can’t tolerate or haven’t had success with two other weight loss drugs. Acomplia is
